{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:13:52Z","timestamp":1786479232976,"version":"build-2736575974"},"reference-count":131,"publisher":"Oxford University Press (OUP)","issue":"16","license":[{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 NS081089-01"],"award-info":[{"award-number":["R21 NS081089-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["PBR06"],"award-info":[{"award-number":["PBR06"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taube Philanthropies"},{"DOI":"10.13039\/100001212","name":"Koret Foundation","doi-asserted-by":"publisher","award":["12-0160"],"award-info":[{"award-number":["12-0160"]}],"id":[{"id":"10.13039\/100001212","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wilma Marvelle Jones Huntington Disease Research Fund and Jean Perkins Foundation"},{"name":"Taube Philanthropies and the Koret Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,15]]},"DOI":"10.1093\/hmg\/ddy202","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T19:07:05Z","timestamp":1527016025000},"page":"2893-2912","source":"Crossref","is-referenced-by-count":44,"title":["TSPO\u2013PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington\u2019s disease: preclinical evidence with the p75NTR ligand LM11A-31"],"prefix":"10.1093","volume":"27","author":[{"given":"Danielle A","family":"Simmons","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L","family":"James","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA"},{"name":"Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia P","family":"Belichenko","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Semaan","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Condon","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Kuan","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J","family":"Shuhendler","sequence":"additional","affiliation":[{"name":"Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick T","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M","family":"Longo","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"key":"key\n\t\t\t\t20180803115949_ddy202-B1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B5","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1172\/JCI74809","article-title":"Neurotrophin receptor p75(NTR) mediates Huntington\u2019s disease-associated synaptic and memory dysfunction","volume":"124","author":"Brito","year":"2014","journal-title":"J. Clin. Invest"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2014.05.032","article-title":"Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington\u2019s disease","volume":"83","author":"Plotkin","year":"2014","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B7","first-page":"4920","article-title":"A small molecule p75NTR ligand normalizes signalling and reduces Huntington\u2019s disease phenotypes in R6\/2 and BACHD mice","volume":"25","author":"Simmons","year":"2016","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington\u2019s disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JHD-170275","article-title":"Modulating neurotrophin receptor signaling as a therapeutic strategy for Huntington\u2019s disease","volume":"6","author":"Simmons","year":"2017","journal-title":"J. Huntington\u2019s Dis"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B11","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1038\/cddis.2013.116","article-title":"Imbalance of p75(NTR)\/TrkB protein expression in Huntington\u2019s disease: implication for neuroprotective therapies","volume":"4","author":"Brito","year":"2013","journal-title":"Cell Death Dis"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B12","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1093\/hmg\/ddv218","article-title":"Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington\u2019s disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation","volume":"24","author":"Miguez","year":"2015","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.nbd.2015.08.008","article-title":"Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington\u2019s disease","volume":"82","author":"Ma","year":"2015","journal-title":"Neurobiol. Dis"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington\u2019s disease","volume":"18","author":"Zuccato","year":"2007","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B15","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1523\/JNEUROSCI.3547-05.2006","article-title":"Small, nonpeptide p75NTR ligands induce survival signaling and inhibit proNGF-induced death","volume":"26","author":"Massa","year":"2006","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B16","doi-asserted-by":"crossref","first-page":"e3604.","DOI":"10.1371\/journal.pone.0003604","article-title":"Small molecule, non-peptide p75 ligands inhibit Abeta-induced neurodegeneration and synaptic impairment","volume":"3","author":"Yang","year":"2008","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fneur.2017.00011","article-title":"Molecular imaging markers to track Huntington\u2019s disease pathology","volume":"8","author":"Wilson","year":"2017","journal-title":"Front. Neurol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.drudis.2014.03.002","article-title":"Biomarker development for Huntington\u2019s disease","volume":"19","author":"Andre","year":"2014","journal-title":"Drug Discov. Today"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(11)70070-9","article-title":"Development of biomarkers for Huntington\u2019s disease","volume":"10","author":"Weir","year":"2011","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B23","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00259-016-3324-6","article-title":"Current status of PET imaging in Huntington\u2019s disease","volume":"43","author":"Pagano","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-319-57193-5_5","article-title":"The complexity of clinical Huntington\u2019s disease: developments in molecular genetics, neuropathology and neuroimaging biomarkers","volume":"15","author":"Tippett","year":"2017","journal-title":"Adv. Neurobiol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B25","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1084\/jem.20160776","article-title":"Potential biomarkers to follow the progression and treatment response of Huntington\u2019s disease","volume":"213","author":"Disatnik","year":"2016","journal-title":"J. Exp. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2990.2008.01006.x","article-title":"Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain","volume":"35","author":"Cosenza-Nashat","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B27","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/glia.20558","article-title":"Translocator protein 18 kDa is involved in the regulation of reactive gliosis","volume":"55","author":"Veiga","year":"2007","journal-title":"Glia"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pneurobio.2006.10.002","article-title":"The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging","volume":"80","author":"Venneti","year":"2006","journal-title":"Prog. Neurobiol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/glia.10144","article-title":"Visualising microglial activation in vivo","volume":"40","author":"Banati","year":"2002","journal-title":"Glia"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(97)00967-1","article-title":"Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington\u2019s disease","volume":"241","author":"Me\u00dfmer","year":"1998","journal-title":"Neurosci. Lett"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2007.12.004","article-title":"Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair","volume":"118","author":"Chen","year":"2008","journal-title":"Pharmacol. Ther"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B32","doi-asserted-by":"crossref","first-page":"785.","DOI":"10.3390\/ijms18040785","article-title":"Translocator protein-18 kDa (TSPO) positron emission tomography (PET) imaging and its clinical impact in neurodegenerative diseases","volume":"18","author":"Dupont","year":"2017","journal-title":"Int. J. Mol. Sci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B33","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/glia.20526","article-title":"Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington\u2019s disease","volume":"55","author":"Simmons","year":"2007","journal-title":"Glia"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington\u2019s disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B35","doi-asserted-by":"crossref","first-page":"541259","DOI":"10.1155\/2013\/541259","article-title":"The role of the immune system in Huntington\u2019s disease","volume":"2013","author":"Ellrichmann","year":"2013","journal-title":"Clin. Dev. Immunol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B36","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2011.09.003","article-title":"Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease","volume":"45","author":"Franciosi","year":"2012","journal-title":"Neurobiol. Dis"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased complement biosynthesis by microglia and complement activation on neurons in Huntington\u2019s disease","volume":"159","author":"Singhrao","year":"1999","journal-title":"Exp. Neurol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B39","doi-asserted-by":"crossref","first-page":"193.","DOI":"10.3389\/fnagi.2017.00193","article-title":"Microglial activation in the pathogenesis of Huntington\u2019s disease","volume":"9","author":"Yang","year":"2017","journal-title":"Front. Aging Neurosci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B40","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-010-0430-7","article-title":"Neuroinflammation in Huntington\u2019s disease","volume":"117","author":"Moller","year":"2010","journal-title":"J. Neural. Transm"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B41","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/brain\/awn244","article-title":"Hypothalamic involvement in Huntington\u2019s disease: an in vivo PET study","volume":"131","author":"Politis","year":"2008","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B42","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","article-title":"Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington\u2019s disease gene carriers","volume":"83","author":"Politis","year":"2015","journal-title":"Neurobiol. Dis"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B44","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington\u2019s disease: a multimodal imaging study","volume":"32","author":"Politis","year":"2011","journal-title":"Hum. Brain Mapp"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B45","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington\u2019s disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B46","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainresbull.2006.10.029","article-title":"Imaging microglial activation in Huntington\u2019s disease","volume":"72","author":"Tai","year":"2007","journal-title":"Brain Res. Bull"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B47","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2967\/jnumed.114.141648","article-title":"PET imaging of translocator protein (18 kDa) in a mouse model of Alzheimer\u2019s disease using N-(2,5-dimethoxybenzyl)-2-18F-fluoro-N-(2-phenoxyphenyl) acetamide","volume":"56","author":"James","year":"2015","journal-title":"J. Nucl. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2967\/jnumed.109.068064","article-title":"Biodistribution and radiation dosimetry in humans of a new PET ligand, (18)F-PBR06, to image translocator protein (18 kDa)","volume":"51","author":"Fujimura","year":"2010","journal-title":"J. Nucl. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B49","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2967\/jnumed.108.060186","article-title":"Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06","volume":"50","author":"Fujimura","year":"2009","journal-title":"J. Nucl. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/syn.20394","article-title":"Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain","volume":"61","author":"Imaizumi","year":"2007","journal-title":"Synapse"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B51","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/jm8011855","article-title":"Single-step high-yield radiosynthesis and evaluation of a sensitive 18F-labeled ligand for imaging brain peripheral benzodiazepine receptors with PET","volume":"52","author":"Briard","year":"2009","journal-title":"J. Med. Chem"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neurobiolaging.2016.04.011","article-title":"11)C-PBR28 binding to translocator protein increases with progression of Alzheimer\u2019s disease","volume":"44","author":"Kreisl","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B53","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1021\/acs.jmedchem.7b00432","article-title":"A facile radiolabeling of [18F]FDPA via spirocyclic iodonium ylides: preliminary PET imaging studies in preclinical models of neuroinflammation","volume":"60","author":"Wang","year":"2017","journal-title":"J. Med. Chem"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B54","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2967\/jnumed.109.062265","article-title":"Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans","volume":"50","author":"Endres","year":"2009","journal-title":"J. Nucl. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B55","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1016\/j.bmc.2005.06.030","article-title":"Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand","volume":"13","author":"James","year":"2005","journal-title":"Bioorganic Med. Chem"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B56","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2967\/jnumed.106.036764","article-title":"11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation","volume":"48","author":"Boutin","year":"2007","journal-title":"J. Nucl. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jamaneurol.2016.3764","article-title":"Imaging of glial cell activation and white matter integrity in brains of active and recently retired national football league players","volume":"74","author":"Coughlin","year":"2017","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B58","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2967\/jnumed.107.046151","article-title":"DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization","volume":"49","author":"James","year":"2008","journal-title":"J. Nucl. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B59","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/jcbfm.2012.46","article-title":"Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA","volume":"32","author":"Mizrahi","year":"2012","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00259-014-2939-8","article-title":"18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke","volume":"42","author":"Boutin","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B61","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.bmcl.2011.12.084","article-title":"[(1)(8)F]GE-180: a novel fluorine-18 labelled PET tracer for imaging Translocator protein 18 kDa (TSPO)","volume":"22","author":"Wadsworth","year":"2012","journal-title":"Bioorganic Med. Chem. Lett"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B62","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2967\/jnumed.115.169078","article-title":"Flutriciclamide (18F-GE180) PET: first-in-human PET study of novel third generation in vivo marker of human translator protein","volume":"57","author":"Fan","year":"2016","journal-title":"J. Nucl. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B63","doi-asserted-by":"crossref","first-page":"84.","DOI":"10.1186\/s13550-017-0334-8","article-title":"Comparison of four 11C-labeled PET ligands to quantify translocator protein 18 kDa (TSPO) in human brain: (R)-PK11195, PBR28, DPA-713, and ER176-based on recent publications that measured specific-to-non-displaceable ratios","volume":"7","author":"Fujita","year":"2017","journal-title":"EJNMMI Res"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B64","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2967\/jnumed.116.178996","article-title":"11C-ER176, a radioligand for 18-kDa translocator protein, Has adequate sensitivity to robustly image all three affinity genotypes in human brain","volume":"58","author":"Ikawa","year":"2017","journal-title":"J. Nucl. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B65","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B66","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1523\/JNEUROSCI.1310-13.2013","article-title":"A small molecule TrkB ligand reduces motor impairment and neuropathology in R6\/2 and BACHD mouse models of Huntington\u2019s disease","volume":"33","author":"Simmons","year":"2013","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B67","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.2250-09.2009","article-title":"Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington\u2019s disease","volume":"29","author":"Wacker","year":"2009","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B68","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.nucmedbio.2014.11.009","article-title":"In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET","volume":"42","author":"Vicidomini","year":"2015","journal-title":"Nucl. Med. Biol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B69","doi-asserted-by":"crossref","first-page":"15716","DOI":"10.1523\/JNEUROSCI.0996-15.2015","article-title":"In vivo detection of age- and disease-related increases in neuroinflammation by 18F-GE180 TSPO MicroPET imaging in wild-type and Alzheimer\u2019s transgenic mice","volume":"35","author":"Liu","year":"2015","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B70","doi-asserted-by":"crossref","first-page":"17317","DOI":"10.1016\/S0021-9258(19)77838-7","article-title":"Purification and characterization of a protein associated with peripheral-type benzodiazepine binding sites","volume":"263","author":"Antkiewicz-Michaluk","year":"1988","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B71","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/hmg\/ddn428","article-title":"Adipose tissue dysfunction tracks disease progression in two Huntington\u2019s disease mouse models","volume":"18","author":"Phan","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B72","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/hmg\/10.2.145","article-title":"Abnormalities in the functioning of adipocytes from R6\/2 mice that are transgenic for the Huntington\u2019s disease mutation","volume":"10","author":"Fain","year":"2001","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B73","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0969-8051(00)00137-2","article-title":"Graphical analysis of PET data applied to reversible and irreversible tracers","volume":"27","author":"Logan","year":"2000","journal-title":"Nucl. Med. Biol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B74","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/jcbfm.2011.107","article-title":"Image-derived input function for brain PET studies: many challenges and few opportunities","volume":"31","author":"Zanotti-Fregonara","year":"2011","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B75","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.7150\/thno.17666","article-title":"[18F]GE-180 PET detects reduced microglia activation after LM11A-31 therapy in a mouse model of Alzheimer\u2019s disease","volume":"7","author":"James","year":"2017","journal-title":"Theranostics"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B76","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/jcbfm.2013.243","article-title":"Noninvasive quantification of metabotropic glutamate receptor type 1 with [(1)(1)C]ITDM: a small-animal PET study","volume":"34","author":"Yamasaki","year":"2014","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B77","doi-asserted-by":"crossref","first-page":"72.","DOI":"10.1186\/s13550-016-0226-3","article-title":"Test\u2013retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer\u2019s disease","volume":"6","author":"Nair","year":"2016","journal-title":"EJNMMI Res"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B78","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.sult.2010.10.001","article-title":"Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy","volume":"31","author":"Kinahan","year":"2010","journal-title":"Semin. Ultrasound CT MR"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B79","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2004.12.011","article-title":"Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6\/2 mouse model of Huntington\u2019s disease","volume":"231","author":"Wang","year":"2005","journal-title":"J. Neurol. Sci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B80","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J. Comp. Neurol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B81","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B82","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/hmg\/ddw050","article-title":"Motor deficits associated with Huntington\u2019s disease occur in the absence of striatal degeneration in BACHD transgenic mice","volume":"25","author":"Mantovani","year":"2016","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B83","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington\u2019s disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B84","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B85","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","article-title":"Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington\u2019s disease","volume":"29","author":"Southwell","year":"2009","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B86","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1006\/bbrc.1996.1112","article-title":"A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage","volume":"224","author":"Imai","year":"1996","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","article-title":"Microglia-specific localisation of a novel calcium binding protein, Iba1","volume":"57","author":"Ito","year":"1998","journal-title":"Brain. Res. Mol. Brain Res"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B88","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0092-8674(92)90164-8","article-title":"The small GTP-binding protein rac regulates growth factor-induced membrane ruffling","volume":"70","author":"Ridley","year":"1992","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anthesiol. Clin"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B90","doi-asserted-by":"crossref","first-page":"10809","DOI":"10.1523\/JNEUROSCI.1487-12.2012","article-title":"Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging","volume":"32","author":"Lavisse","year":"2012","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B91","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/brain\/123.11.2321","article-title":"The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity","volume":"123","author":"Banati","year":"2000","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B92","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mcn.2016.10.007","article-title":"Systemic application of AAV vectors targeting GFAP-expressing astrocytes in Z-Q175-KI Huntington\u2019s disease mice","volume":"77","author":"Vagner","year":"2016","journal-title":"Mol. Cell. Neurosci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B93","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice","volume":"17","author":"Tong","year":"2014","journal-title":"Nat. Neurosci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B94","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/NEN.0b013e318188b204","article-title":"The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders","volume":"67","author":"Venneti","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B95","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.coph.2015.09.008","article-title":"Disruption of immune cell function by mutant huntingtin in Huntington\u2019s disease pathogenesis","volume":"26","author":"Andre","year":"2016","journal-title":"Curr. Opin. Pharmacol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B96","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1172\/JCI11916","article-title":"NF-kappaB in neuronal plasticity and neurodegenerative disorders","volume":"107","author":"Mattson","year":"2001","journal-title":"J. Clin. Invest"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B97","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","article-title":"Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity","volume":"24","author":"Khoshnan","year":"2004","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B98","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/brain\/awt355","article-title":"HTT-lowering reverses Huntington\u2019s disease immune dysfunction caused by NFkappaB pathway dysregulation","volume":"137","author":"Trager","year":"2014","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B99","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11307-017-1099-1","article-title":"Increased expression of translocator protein (TSPO) marks pro-inflammatory microglia but does not predict neurodegeneration","volume":"20","author":"Beckers","year":"2018","journal-title":"Mol. Imaging Biol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B100","doi-asserted-by":"crossref","first-page":"3.","DOI":"10.1186\/1742-2094-11-3","article-title":"Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis","volume":"11","author":"Karlstetter","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B101","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0006-8993(91)90028-T","article-title":"Increase in omega 3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumour necrosis factor-alpha and lipopolysaccharide","volume":"543","author":"Bourdiol","year":"1991","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B102","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nbd.2003.07.002","article-title":"Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro","volume":"14","author":"Wilms","year":"2003","journal-title":"Neurobiol. Dis"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B103","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B104","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington\u2019s disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B105","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-160196","article-title":"Cerebrospinal fluid biomarkers for Huntington\u2019s disease","volume":"5","author":"Byrne","year":"2016","journal-title":"J. Huntington\u2019s Dis"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B107","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B108","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JHD-160213","article-title":"Plasma cytokine levels in relation to neuropsychiatric symptoms and cognitive dysfunction in Huntington\u2019s disease","volume":"5","author":"Bouwens","year":"2016","journal-title":"J. Huntington\u2019s Dis"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B109","doi-asserted-by":"crossref","first-page":"RRN1231.","DOI":"10.1371\/currents.RRN1231","article-title":"Abnormal peripheral chemokine profile in Huntington\u2019s disease","volume":"3","author":"Wild","year":"2011","journal-title":"PLoS Curr"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immun"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B111","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2967\/jnumed.114.149955","article-title":"In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis","volume":"56","author":"Airas","year":"2015","journal-title":"J. Nucl. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B112","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s00259-016-3391-8","article-title":"In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [(18)F]GE-180 and effect of docosahexaenoic acid","volume":"43","author":"Tremoleda","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B113","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.2967\/jnumed.116.183020","article-title":"Evaluation of the effect of fingolimod treatment on microglial activation using serial PET imaging in multiple sclerosis","volume":"58","author":"Sucksdorff","year":"2017","journal-title":"J. Nucl. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B114","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bbadis.2010.04.009","article-title":"Mouse models in neurological disorders: applications of non-invasive imaging","volume":"1802","author":"Waerzeggers","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B115","first-page":"1","article-title":"Region-based partial volume correction techniques for PET imaging: sinogram implementation and robustness","volume":"2013","author":"Sattarivand","year":"2013","journal-title":"Int. J. Mol. Imaging"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B116","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00259-010-1622-y","article-title":"Comparison of 18F- and 11C-labeled aryloxyanilide analogs to measure translocator protein in human brain using positron emission tomography","volume":"38","author":"Dickstein","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B117","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s00259-008-0908-9","article-title":"Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers","volume":"35","author":"Chauveau","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B118","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/aww017","article-title":"Early and protective microglial activation in Alzheimer\u2019s disease: a prospective study using 18F-DPA-714 PET imaging","volume":"139","author":"Hamelin","year":"2016","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","article-title":"An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28","volume":"32","author":"Owen","year":"2012","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B120","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1042\/BST20150058","article-title":"The methodology of TSPO imaging with positron emission tomography","volume":"43","author":"Turkheimer","year":"2015","journal-title":"Biochem. Soc. Trans"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B121","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2967\/jnumed.112.118885","article-title":"Influence of TSPO genotype on 11C-PBR28 standardized uptake values","volume":"54","author":"Yoder","year":"2013","journal-title":"J. Nucl. Med"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B122","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI80743","article-title":"Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients","volume":"125","author":"Wild","year":"2015","journal-title":"J. Clin. Invest"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B123","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/prca.201400073","article-title":"Challenges of Huntington\u2019s disease and quest for therapeutic biomarkers","volume":"9","author":"Kotrcova","year":"2015","journal-title":"Proteomics Clin. Appl"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B124","doi-asserted-by":"crossref","first-page":"1.","DOI":"10.1155\/2016\/8653132","article-title":"Neuroimmunology of Huntington\u2019s disease: revisiting evidence from human studies","volume":"2016","author":"Rocha","year":"2016","journal-title":"Mediators Inflamm"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.nbd.2010.10.015","article-title":"Brief ampakine treatments slow the progression of Huntington\u2019s disease phenotypes in R6\/2 mice","volume":"41","author":"Simmons","year":"2011","journal-title":"Neurobiol. Dis"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B126","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1523\/JNEUROSCI.0620-09.2009","article-title":"The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo","volume":"29","author":"Knowles","year":"2009","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B127","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.neurobiolaging.2013.02.015","article-title":"A small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer\u2019s mouse model","volume":"34","author":"Knowles","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11307-013-0664-5","article-title":"PET imaging of stroke-induced neuroinflammation in mice using [18F]PBR06","volume":"16","author":"Lartey","year":"2014","journal-title":"Mol. Imaging Biol"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B129","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jps.2600830718","article-title":"Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil","volume":"83","author":"Gandelman","year":"1994","journal-title":"J. Pharm. Sci"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B130","doi-asserted-by":"crossref","first-page":"8272","DOI":"10.1021\/jm300371c","article-title":"New positron emission tomography (PET) radioligand for imaging sigma-1 receptors in living subjects","volume":"55","author":"James","year":"2012","journal-title":"J. Med. Chem"},{"key":"key\n\t\t\t\t20180803115949_ddy202-B131","volume-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"2008"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/27\/16\/2893\/25428283\/ddy202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:49:36Z","timestamp":1661302176000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/27\/16\/2893\/5025680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":131,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2018,5,30]]},"published-print":{"date-parts":[[2018,8,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddy202","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8,15]]},"published":{"date-parts":[[2018,5,30]]}}}